Docetaxel trihydrate (Bio-Synectics)

N/A

Report date: 2022/10/13 11:25:46

Base Information

Drug NameDocetaxel trihydrate (Bio-Synectics)

Drug Alias NameIncrementally modified drug (IMD) of Taxotere (Bio-Synectics)BS-102

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTubulin depolymerization inhibitors

TargetsTubulin

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBio-Synectics Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A